Organization
Sarepta Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Sarepta Therapeutics, Inc.
... CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... federal government to take title to five patents on eteplirsen, marketed by Sarepta Therapeutics under the brand name Exondys 51.The groups, which include Patients for ...
... groups argued that the patents — either owned or licensed by Sarepta Therapeutics Inc. — failed to disclose federal funding for grants that were used ...
... 6:09 PM EDT) -- The First Circuit on Wednesday sided with Sarepta Therapeutics Inc. in a lawsuit claiming the company hid concerns about the clinical ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... to the investment community. Today we are offering reports on RIOT, SAGE, SRPT, and SRRA which can be accessed for free by signing up tohttp://www.wallstequities.com/registration. ...
... year-end 2018 -- CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... 31, 2017 -- CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... shareholders of Morgan Stanley (NYSE:MS), Novavax, Inc. (NASDAQ:NVAX), Xerox Corporation (NYSE:XRX), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Semgroup Corporation (NYSE:SEMG), and Toll Brothers Inc. (NYSE:TOL), including updated ...
... research to the investment community. Today we are offering reports on SAGE, SRPT, SRRA, and SRNE which can be accessed for free by signing up ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... ever-changing industry. Included in today's commentary: Propanc Biopharma, Inc.(OTC: PPCB, Sarepta Therapeutics, Inc. (NASDAQ: SRPT), ImmunoGen, Inc. (NASDAQ: IMGN), PTC Therapeutics, Inc. (NASDAQ: PTCT), and ...
... over a decade of research a gratifying experience." Last year, Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... SAN FRANCISCO - Sarepta Therapeutics, Inc.(NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
Subscribe now for full coverage on Sarepta Therapeutics, Inc.
Start My Free Trial